M08.29
Juvenile rheumatoid arthritis with systemic onset, multiple sites
Clinical Classification Guidelines
Medical Intelligence & Overview
Juvenile rheumatoid arthritis (JRA), also known as juvenile idiopathic arthritis (JIA), is a chronic autoimmune disorder affecting children. The specific type classified under ICD-10 code M08.29 is juvenile rheumatoid arthritis with systemic onset, characterized by widespread inflammation that can involve multiple parts of the body. This form of arthritis typically appears in young children and can lead to various health challenges if not properly managed. Understanding this condition is essential for recognizing symptoms early and seeking appropriate care.
Causes & Symptoms
Clinical Causes: The exact cause of juvenile rheumatoid arthritis with systemic onset is unknown. The condition involves the immune system mistakenly attacking healthy tissues, leading to inflammation. Genetic factors may increase susceptibility, though no single gene has been identified as a direct cause. Environmental triggers, such as infections, are thought to potentially play a role in initiating the immune response.
Key Symptoms: Persistent high fever, especially spikes occurring once or twice daily Widespread joint swelling and pain, affecting multiple joints including knees, wrists, and ankles Rash that appears during febrile episodes, often salmon-pink and non-itchy Fatigue and irritability Delayed growth or occasional limp due to joint pain Enlargement of lymph nodes, liver, or spleen in some cases Symptoms may fluctuate with periods of flare-ups and remission
Diagnostic & Treatment
Diagnosis Path: Complete blood count (CBC) to check for anemia and inflammation markers Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels to assess inflammation Liver and kidney function tests Rheumatoid factor (RF) and antinuclear antibodies (ANA) tests, although these are often negative in systemic JRA Imaging such as X-rays or MRI scans to evaluate joint damage or inflammation
Treatment Protocols: Nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce pain and inflammation Corticosteroids for severe symptoms or during flare-ups Disease-modifying antirheumatic drugs (DMARDs), such as methotrexate, to slow disease progression Biologic agents targeting specific immune pathways, used in more severe cases Physical and occupational therapy to maintain joint function and mobility Regular monitoring and supportive care to address symptoms and prevent complications
Clinical Advice & FAQs
Billing Guidance
Is M08.29 a billable ICD-10 code?
Yes, M08.29 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M08.29?
Clinical documentation must specify the nature of Juvenile rheumatoid arthritis with systemic onset, multiple sites and any associated comorbidities for accurate reporting.
Cite this Clinical Reference